NCT06465225

Brief Summary

The aim of the study is to determine the clinical value of using a powered alternating pressure air overlay mattress (P-APAM) in the prevention of pressure injury (PI) in patients at medium to high risk. This study is noncomparative, observational study. Patients older than 18 years of age, with a medium to high risk of PI, without PI, up during the day, and lying between 15 and 20 hours per day on a specific P-APAM will be included. The study will be conducted in nursing homes, and in long-stay geriatrics department. Patients will be followed up for 35 days. The use of the P-APAM is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who will develop at least one PI of at least stage 2 on the sacrum, spine, or heel between day 0 and day 35 . Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 18, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

July 17, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2025

Completed
Last Updated

May 5, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

June 13, 2024

Last Update Submit

May 3, 2026

Conditions

Keywords

automated decompression air mattresspressure ulcerprevention

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients who developed at least one stage 2 pressure injury

    Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)

    35 days after installation on the mattress (at day 35)

Secondary Outcomes (5)

  • Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between

    35 days after installation on the mattress (at day 35)

  • Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)

    35 days after installation on the mattress (at day 35)

  • Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)

    35 days after installation on the mattress (at day 35)

  • Assessment of the degree of maceration

    35 days after installation on the mattress (at day 35)

  • Assessment of mattress safety

    At day 35

Study Arms (1)

Patients in nursing homes or long-stay geriatrics department

Device: Use of a powered alternating pressure air mattress

Interventions

Patients with a medium to high risk of developing pressure injury, without pressure injury, up during the day and lying between 15 and 20 hours per day will ly a on a R'GO Soins overlay mattress

Patients in nursing homes or long-stay geriatrics department

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in nursing homes or long-stay geriatrics department

You may qualify if:

  • Patient over 18 years old
  • Patient with a medium to high risk of developing pressure ulcers (clinical judgment and a score of \[10 to 14\] on the Braden scale (6 (maximum risk) to 23 (no risk))
  • Patient with a weight \< 150kg
  • Patient (or a trusted third party/legal representative) having been informed of the study and signing informed consent

You may not qualify if:

  • Patient at end of life (estimated life expectancy less than 6 months)
  • Patient discharge from the establishment expected within two months
  • Patient with unstable spinal injury or other spinal disorder
  • Patient with cervical or skeletal traction
  • Patient with unstable spinal cord injury
  • Patient with acute multiple trauma
  • Patient with unstable posttraumatic bone fracture
  • A) One or more of the following phenotypic criteria:
  • Significant unintentional weight loss: A weight loss of ≥ 5% within 1 month or ≥ 10% within 6 months Low Body Mass Index (BMI): BMI \< 18.5 kg/m² for individuals under 70 years old, BMI \< 21 kg/m² for individuals aged 70 years and older Reduced Muscle Mass Evident reduction in muscle mass AND
  • B) One of the following etiological criteria:
  • Inadequate nutritional intake:
  • Nutritional intake less than 50% of the energy requirements for more than one week Reduced food intake for more than two weeks Presence of Disease or Stress Metabolism Acute or chronic illness, or any condition causing metabolic stress that increases energy requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Multiples Facilities

Multiple Locations, France

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Sylvie MEAUME, PhD

    Hôpital ROSCHILD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2024

First Posted

June 18, 2024

Study Start

July 17, 2024

Primary Completion

July 8, 2025

Study Completion

July 8, 2025

Last Updated

May 5, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations